Cargando…
Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Non-alcoholic fatty liver disease affects approximately one billion adults worldwide. Non-alcoholic steatohepatitis (NASH) is a progressive disease and underlies the advancement to liver fibrosis, cirrhosis, and hepatocellular carcinoma, for which there are no FDA-approved drug therapies. We develop...
Autores principales: | Hurrell, Tracey, Kastrinou-Lampou, Vlasia, Fardellas, Achilleas, Hendriks, Delilah F. G., Nordling, Åsa, Johansson, Inger, Baze, Audrey, Parmentier, Céline, Richert, Lysiane, Ingelman-Sundberg, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227007/ https://www.ncbi.nlm.nih.gov/pubmed/32295224 http://dx.doi.org/10.3390/cells9040964 |
Ejemplares similares
-
Human hepatic 3D spheroids as a model for steatosis and insulin resistance
por: Kozyra, Mikael, et al.
Publicado: (2018) -
The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
por: Trampuž, Sara Redenšek, et al.
Publicado: (2023) -
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
por: Hendriks, Delilah F. G., et al.
Publicado: (2016) -
Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran
por: Neve, Etienne P. A., et al.
Publicado: (2015) -
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
por: Bell, Catherine C., et al.
Publicado: (2016)